Premier Path Wealth Partners, LLC

Position in MRK — Merck & Co., Inc.

CIK 1999925 MADISON, NJ

Position in MRK

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,430,577

+$316,240 QoQ

Shares Held

18,915

+7.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#1,471

of 3,778 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Premier Path Wealth Partners, LLC holds $28,672,526 across 10 Drug Manufacturers - General names. MRK ranks #4 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	7,275	$8,725,853
2	JNJ	Johnson & Johnson	23,211	$5,894,897
3	ABBV	AbbVie Inc.	13,169	$3,313,847
4	MRK	Merck & Co., Inc. This page	18,915	$2,430,577
5	AMGN	Amgen Inc	6,238	$2,258,904
6	GILD	Gilead Sciences, Inc.	16,156	$2,041,149
7	BMY	Bristol Myers Squibb Co	28,219	$1,625,978
8	PFE	Pfizer Inc	49,426	$1,190,178

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,430,577	18,915	+7.6%	Shares	Sole	2026-07-21
2026-03-31	$2,114,337	17,577	+27.1%	Shares	Sole	2026-04-23
2025-12-31	$1,455,640	13,829	+18.3%	Shares	Sole	2026-01-22
2025-09-30	$981,225	11,691	+27.6%	Shares	Sole	2025-11-04
2025-06-30	$725,422	9,164	-24.4%	Shares	Sole	2025-08-04
2025-03-31	$1,088,429	12,126	-4.7%	Shares	Sole	2025-04-21
2024-12-31	$1,265,783	12,724	-13.7%	Shares	Sole	2025-01-15
2024-09-30	$1,673,420	14,736	-5.1%	Shares	Sole	2024-10-15
2024-06-30	$1,921,499	15,521	+8.2%	Shares	Sole	2024-07-24
2024-03-31	$1,892,558	14,343	+0.1%	Shares	Sole	2024-04-24
2023-12-31	$1,562,801	14,335	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.